U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173790) titled 'Watch and Wait or Worry and Wait in Indolent Lymphoma' on Sept. 08.
Brief Summary: Indolent lymphomas, including chronic lymphocytic leukemia/small lymphocytic lymphoma, marginal zone lymphoma, low-grade follicular lymphoma, and Waldenstrom macroglobulinemia, are slow-growing cancers often managed initially with a watchful waiting strategy. This approach avoids unnecessary side effects of early therapy but may negatively impact patients' quality of life (QoL) due to anxiety, uncertainty, and self-monitoring of symptoms. Previous studies such as McCaughan et al. (2023) and Tsang et al. (2023) have reported increased distress and gre...